A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

• Published in: Leukemia Vol. 33; no. 12; pp. 2974 - 2978
• Main Authors: Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E., Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Salama, M. E., Weinberg, R. S., Rampal, R., Goldberg, J. D., Mesa, R., Dueck, A. C., Hoffman, R.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.12.2019; Nature Publishing Group
• Subjects: 692/699/1541/1990; 692/699/1541/1990/2331; Biological response modifiers; Blood clot; Cancer Research; Critical Care Medicine; Hematology; Humans; Intensive; Interferon; Interferon alpha; Interferon-alpha - administration & dosage; Interferon-alpha - adverse effects; Interferon-alpha - therapeutic use; Internal Medicine; Letter; Medicine; Medicine & Public Health; Mesenteric Veins - pathology; Oncology; Polycythemia; Polycythemia vera; Polycythemia Vera - complications; Polycythemia Vera - diagnosis; Polycythemia Vera - drug therapy; Polycythemia Vera - etiology; Polyethylene Glycols - administration & dosage; Polyethylene Glycols - adverse effects; Polyethylene Glycols - therapeutic use; Prospective Studies; Recombinant Proteins - administration & dosage; Recombinant Proteins - adverse effects; Recombinant Proteins - therapeutic use; Thrombocythemia, Essential - complications; Thrombocythemia, Essential - diagnosis; Thrombocythemia, Essential - drug therapy; Thrombocythemia, Essential - etiology; Thromboembolism; Thrombosis; Venous Thrombosis - diagnosis; Venous Thrombosis - etiology; Venous Thrombosis - therapy; Viral antigens; α-Interferon
• ISSN: 0887-6924; 1476-5551
• DOI: 10.1038/s41375-019-0524-7